History and Purpose
In 1998, to enhance the interaction between the functional GI disease patient community, the clinicians who care for them and the companies that provide the diagnostics, pharmaceuticals and other products used in their care, we formed the IFFGD Industry Council. The Council facilitates communication between IFFGD and the member companies and ensures that the voice of our patients is heard. The Industry Council helps fulfil IFFGD’s mission- to inform, assist, and support people affected by gastrointestinal disorders.
We invite participation from companies with a demonstrated interest in these disorders. Note that while we are grateful to our Industry Council supporters, we do not endorse any specific product or company.
Our Industry Council
Takeda Pharmaceutical Company Ltd.
Arena Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc.
Evoke Pharma, Inc.
Mauna Kea Technologies, Inc., Creators of Cellvizio
Summit Therapeutics Inc.
See Industry Expanded Patient Assistance and Industry Research and Trials on COVID-19 here
Inquiries regarding participation in the IFFGD Industry Council should be directed to:
Ceciel T. Rooker, President
3015 Dunes West Blvd, Suite 512
Mount Pleasant, SC 29466